NFKB1 and cancer: Inhibition of NF-κB has been shown to impede the transcription of CDH2, SLUG, TWIST1 and SNAIL in some cancer cell lines [188,189,190,191] and NF-κB activation by TNF or expression of constitutively active IKK2 can induce an EMT-phenotype [187].